EU Trademark Reform Advances; Dutch Warn Of Holdup Of Goods In Transit 10/11/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The European Union Council of ministers today adopted its position on the reform of the European trademark system. The Netherlands delegation abstained from voting out of concern that the proposed reform introduces the possibility to stop goods in transit for possible intellectual property infringement.
Medicines Patent Pool Expands To Include Hepatitis C, Tuberculosis 09/11/2015 by Intellectual Property Watch 1 Comment The Medicines Patent Pool has announced the expansion of its mandate to cover hepatitis C and tuberculosis treatment. The MPP was previously concentrating only on HIV medicines.
LDC Coordinator Thanks WTO For ‘Accountability To Humanity’ On Pharma IP 08/11/2015 by Intellectual Property Watch Leave a Comment Last week’s decision by a World Trade Organization committee to allow least-developed countries to not apply global IP rules for pharmaceuticals for 17 more years made WTO members accountable to humanity, the coordinator of the LDC Group has said. Pharmaceuticals are different from all other forms of IP, he said.
LDC Pharma IP Waiver Until 2033 Approved By WTO TRIPS Council 06/11/2015 by Catherine Saez, Intellectual Property Watch 3 Comments After two weeks of high level negotiations between the United States and the Group of Least-Developed Countries, the World Trade Organization committee on intellectual property rights today agreed to extend a waiver allowing LDCs to avoid applying and enforcing IP rights on pharmaceutical products until 2033.
TPP Text Is Out, Finally, With Lots Of Bilateral Specialities 06/11/2015 by Monika Ermert for Intellectual Property Watch and William New Leave a Comment Four weeks after the finalisation of the agreement, the final text of the Trans-Pacific Partnership (TPP) was finally released by the United States and other partners of the first of the regional mega-trade deals. The parties hurried to underline the success of the negotiations, but early reactions were deeply divided.
Public Health Considerations Should Guide Patent Examination, Paper Argues 05/11/2015 by Intellectual Property Watch Leave a Comment Patent offices should align their work in support of national health and medicines policies when carrying out the examination of patents, a new South Centre paper argues.
17 Year Exemption From Pharmaceutical Patents Agreed At WTO – TWN 03/11/2015 by Intellectual Property Watch, Intellectual Property Watch 1 Comment From Third World Network: London, 3 Nov (Sangeeta Shashikant) The United States and the Least Developed Countries (LDCs) at the World Trade Organization have reached agreement ad referendum on a pharmaceutical patent exemption for a duration of 17 years, according to trade diplomats.
Expert: As A UN Agency, WIPO Has Role To Play On Neglected Diseases 02/11/2015 by Catherine Saez, Intellectual Property Watch 2 Comments According to a prominent researcher in the field of neglected tropical diseases, the World Intellectual Property Organization has a prominent role to play in addressing the lack of research and development for neglected diseases.
Panellists: Price Is Main Barrier To Medicines Access In Rich And Poor Countries 30/10/2015 by Catherine Saez, Intellectual Property Watch 2 Comments A joint symposium of the World Health Organization, World Trade Organization and World Intellectual Property Organization this week included several panels on how trade, public health and intellectual property could positively interact to increase access to medicines.
High-Level Negotiations On LDC Pharma IP Waiver Extension At WTO 30/10/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Negotiations have been ongoing at the World Trade Organization over the extension of a waiver allowing least-developed countries not to grant or enforce intellectual property rights on pharmaceutical products.